Navigation Links
New cancer-fighting strategy focuses on signaling molecules
Date:2/24/2010

Cancer researchers studying the immune system have identified a previously unrecognized set of targets and biomarkers to battle solid tumors.

The findings center on discovery of signaling molecules that are major players in a biochemical mechanism linking certain actions of B cells to solid tumor growth. The most notable implication of the study is that a drug in use for more than decade to treat non-Hodgkin's lymphoma, which is a cancer of the B cells, might be effective against other solid tumors, says lead author Lisa Coussens, PhD, of the UCSF Helen Diller Family Comprehensive Cancer Center.

"This is paradigm shifting," emphasizes Coussens, who is a pioneer in studying the role of molecular regulation in cellular inflammation that is linked to development of cancer. "The discoveries open up our thinking to many new signaling molecules as potential therapeutic targets.''

The research is published online and in print by the scientific journal "Cancer Cell" (vol.17, issue 2, http://www.cell.com/cancer-cell/current).

"These are very significant findings because they suggest that Rituxan, a drug that we already are familiar with, could have very broad clinical implications in the treatment of some solid tumors,'' says Coussens, who also is a professor in the UCSF Department of Pathology and co-director of the Mouse Pathology Core and Program in Cancer, Immunity and Microenvironment.

The researchers found that a class of antibodies known as immunoglobulin G and the receptors to which they bind play a key role in the link between B cells and solid tumor growth. Called FcRgamma, these receptors are found on cells of the innate immune system (including mast cells, macrophages, and dendritic cells). The activation of FcRgamma plays a part in recruiting circulating immune cells to neoplastic (abnormal) tissue, which in turn enhances development of new blood v
'/>"/>

Contact: Elizabeth Fernandez
efernandez@pubaff.ucsf.edu
415-476-2557
University of California - San Francisco
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. U-Iowa improves delivery of cancer-fighting molecules
2. FSU researcher using computers to hone cancer-fighting strategies
3. Researchers uncover key trigger for potent cancer-fighting marine product
4. Queens researchers propose rethinking renewable energy strategy
5. H1N1 influenza adopted novel strategy to move from birds to humans
6. Skunks strategy not just black and white
7. New strategy for mending broken hearts?
8. Strategy outlined for growing bioenergy while protecting wildlife
9. IEEE-USA President endorses national innovation strategy
10. Science Coalition commends Presidents strategy for innovation
11. New strategy for inhibiting virus replication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Terra satellite show the different areas that have been affected ... The burn scars show up as reddish-brown splotches of color ... the remote parts of Eastern Russia in the Sakha Republic. ... instrument, it is still possible to see the smoke rising ... below show the devastating number of fires that have plagued ...
(Date:7/25/2014)... autism and disrupted brain development is an essential ... is largely unknown. However, thanks to funding from ... Washington University (GW) researcher Anthony-Samuel LaMantia, Ph.D. may ... answers to these key questions in the field ... pharmacology and physiology at the GW School of ...
(Date:7/25/2014)... Nearly 600 scientists from 25 countries and ... Meeting organized by the Genetics Society of America ... in Seattle. The conference will feature close to ... results on topics including gene expression and regulation, ... technologies, evolution, aging, and a variety of diseases. ...
Breaking Biology News(10 mins):GW researcher receives grant to answer the how and why of autism during development 2Yeast meeting to showcase latest breakthroughs in genetics and molecular biology 2
... Alex Pyron,s expertise is in family trees. Who is related ... they are now. But not for humans: reptiles. In ... the island led him to confirm the identity of 60 ... an author on snakes and expert on amphibians and reptiles, ...
... foodborne bacteria Listeria monocytogenes sickens about 2,500 ... worldwide, killing about 25-30% of those infected. Listeriosis is ... , and current methods for detecting the bacteria are ... developing an inexpensive biosensor to detect the pathogen in ...
... laser laboratory operational later this year, he will use ... bonds like a stringed musical instrument. Tokmakoff, the ... at the University of Chicago in January to tackle ... vibrational spectroscopy methods that he has developed. "He ...
Cached Biology News:Sri Lankan snake study reveals new species, rich biodiversity in island country 2Low-cost nano-biosensor to detect foodborne pathogen that causes listeriosis 2Low-cost nano-biosensor to detect foodborne pathogen that causes listeriosis 3Watery research theme to flow through new Tokmakoff lab 2Watery research theme to flow through new Tokmakoff lab 3
(Date:7/25/2014)... 2014 Research and Markets  has ... Market 2014-2018" report to their offering. ... Metabolomics or Metabonomics is the scientific study of ... new experimental technique that is being widely used ... are small molecules that are present in blood, ...
(Date:7/25/2014)... July 25, 2014 The Conferee Networking ... Topics for Conferee Networking. These two-hour sessions provide a ... meet and resolve problems, discuss new techniques, or brainstorm ... to submit a topic for consideration is August 31, ... . The Conferee Networking committee will review the topics, ...
(Date:7/25/2014)... July 25, 2014 /PRNewswire-iReach/ -- Xybion Corporation, the ... global corporations operating in highly regulated industries, announced ... annual Global User Group Conference, Xybion International Exchange, ... Philadelphia, Pennsylvania at the Sheraton Society ... This year,s conference theme ...
(Date:7/24/2014)... Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") announced the publication ... 3 study of Zerenex (ferric citrate), the Company,s investigational ... hyperphosphatemia in patients with end-stage renal disease (ESRD) on ... with FErric CiTrate in EsrD) was published online today ... Nephrology ( JASN ). , This ...
Breaking Biology Technology:Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4
... Inc. (Nasdaq: MITI ), a biopharmaceutical company ... inflammation and autoimmune diseases, today announced that its President ... Future Leaders in the Biotech Industry conference at the ... City on Thursday, April 2, 2009. A simultaneous ...
... Technologies, Inc. (NTI(R)) (Nasdaq: NTII ) announced ... its exclusive financial advisor to assist in the evaluation ... potential sale of the Company or its major assets."We ... efficiently determining if there is a transaction more beneficial ...
... company focused on the discovery and development of ... of microbial,resistance, announces today the appointment of Dr. ... Novexel,s SAB is chaired by Dr.,David Shlaes who ... is currently,Adjunct Professor at the Department of Biology ...
Cached Biology Technology:Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009 2Micromet to Present at the Future Leaders in the Biotech Industry Conference on April 2, 2009 3Neurobiological Technologies Announces Hiring of Advisor to Seek Sale of Company 2Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush 2Novexel Strengthens its Scientific Advisory Board With the Appointment of Dr. Karen Bush 3
Agarose-LE, 250 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Agarose-LE, 500 g. Suitable for soft agarose cloning. Nuclease-free.Gel point (1.5%): 36 1.5 C, EEO (-mr): 1200 g/cm2. Category: Nucleotides & Enzymes & Biochemicals, Ultrapure Biochemicals ....
Request Info...
Biology Products: